Hypocholesterolemia is a risk factor for reduced systemic vascular resistance reactivity during hemodialysis.
- Published in:
- Hypertension Research, 2021, v. 44, n. 8, p. 988, doi. 10.1038/s41440-021-00640-2
- By:
- Publication type:
- Article
Works by Arisato, Tetsuya
Results: 4
1
2
Heparin-induced thrombocytopenia among incident hemodialysis patients anticoagulated with low molecular weight heparin: A single-center retrospective study.
- Published in:
- Nefrologia, 2021, v. 41, n. 3, p. 356, doi. 10.1016/j.nefro.2020.05.012
- By:
- Publication type:
- Article
3
Effects of sodium-glucose co-transporter 2 inhibitors on ultrafiltration in patients with peritoneal dialysis: a protocol for a randomized, double-blind, placebo-controlled, crossover trial (EMPOWERED).
- Published in:
- Clinical & Experimental Nephrology, 2024, v. 28, n. 7, p. 629, doi. 10.1007/s10157-024-02467-w
- By:
- Publication type:
- Article
4
Combined evaluation of plasma B-type natriuretic peptide and urinary liver-type fatty acid-binding protein/creatinine ratio is related to worsening renal function in patients undergoing elective percutaneous coronary intervention.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 12, p. 1319, doi. 10.1007/s10157-021-02113-9
- By:
- Publication type:
- Article